The mutations in NRAS (typically associated with melanomas, multiple myelomas, acute myelogenous leukemia, and thyroid cancer) were, in both cases, the Q61R hotspot mutation in the Ras domain. This evidence concerns the gene NRAS and thyroid gland carcinoma.